Discordance between the patient‘s global assessment of disease activity (PGA) and examiner’s global assessment (EGA) has been described in rheumatoid arthritis (RA) (1,2). Understanding the reasons for this discrepancy is essential in the context of treat-to-target treatment strategy78340341Annual European Congress of Rheumatology (EULAR
ObjectivesThe classification of disease activity states in rheumatoid arthritis (RA) can be achieved...
OBJECTIVE: Patient-physician discordance in global assessment of disease activity concerned one thi...
OBJECTIVE Measurements of disease activity, such as the clinical disease activity score (DAS28) or ...
BACKGROUND:Discordance between patient's global assessment (PtGA) and physician's global assessment ...
Background. In rheumatoid arthritis (RA), global disease activity is commonly evaluated, from the pa...
International audienceObjectiveThe integration of the patient in therapeutic decision-making is impo...
Aim: The aim of the study was to compare the differences between patient global disease activity (Pt...
The aim of the study was to compare the differences between patient global disease activity (PtGDA) ...
Background Discordance between patient’s global assessment (PtGA) and physician’s global assessment ...
Objective To assess the determinants of patients' (PTGL) and physicians' (MDGL) global assessment of...
Objective: To identify the level of agreement between patients with rheumatoid arthritis (RA) and ph...
Abstract Background Discordance between patients with rheumatoid arthritis (RA) and their rheumatolo...
OBJECTIVE Measurements of disease activity, such as the clinical disease activity score (DAS28) o...
Patient-reported outcomes (PROs) reflect the patient's perspective and are used in rheumatoid arthri...
In current management paradigms of Rheumatoid Arthritis (RA), patient global assessment (PGA) is cru...
ObjectivesThe classification of disease activity states in rheumatoid arthritis (RA) can be achieved...
OBJECTIVE: Patient-physician discordance in global assessment of disease activity concerned one thi...
OBJECTIVE Measurements of disease activity, such as the clinical disease activity score (DAS28) or ...
BACKGROUND:Discordance between patient's global assessment (PtGA) and physician's global assessment ...
Background. In rheumatoid arthritis (RA), global disease activity is commonly evaluated, from the pa...
International audienceObjectiveThe integration of the patient in therapeutic decision-making is impo...
Aim: The aim of the study was to compare the differences between patient global disease activity (Pt...
The aim of the study was to compare the differences between patient global disease activity (PtGDA) ...
Background Discordance between patient’s global assessment (PtGA) and physician’s global assessment ...
Objective To assess the determinants of patients' (PTGL) and physicians' (MDGL) global assessment of...
Objective: To identify the level of agreement between patients with rheumatoid arthritis (RA) and ph...
Abstract Background Discordance between patients with rheumatoid arthritis (RA) and their rheumatolo...
OBJECTIVE Measurements of disease activity, such as the clinical disease activity score (DAS28) o...
Patient-reported outcomes (PROs) reflect the patient's perspective and are used in rheumatoid arthri...
In current management paradigms of Rheumatoid Arthritis (RA), patient global assessment (PGA) is cru...
ObjectivesThe classification of disease activity states in rheumatoid arthritis (RA) can be achieved...
OBJECTIVE: Patient-physician discordance in global assessment of disease activity concerned one thi...
OBJECTIVE Measurements of disease activity, such as the clinical disease activity score (DAS28) or ...